ScholarLens Back to search
2007•CHEST JournalRequires access

AN OPEN LABEL STUDY OF ARFORMOTEROL INHALATION SOLUTION AND RACEMIC FORMOTEROL DRY POWDER INHALER IN SUBJECTS WITH COPD

Jahnavi Kharidia, Charles Fogarty, Craig LaForce, Gary Maier, Roger Hsu, Shelly Dunnington, Lisa Curry, Rudolf A. Baumgartner, John P. Hanrahan

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Formoterol, Dry-powder inhaler, Medicine, COPD, Bronchoconstriction, Inhalation, Inhaler, Formoterol Fumarate

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
AN OPEN LABEL STUDY OF ARFORMOTEROL INHALATION SOLUTION AND RACEMIC FORMOTEROL DRY POWDER INHALER IN SUBJECTS WITH COPD — Research Paper | ScholarLens